EUVIMEDEUVIMED entdecken
Crossref

APOE genotype and astrocyte activity collectively influence AD biomarkers and Aβ burden

Weineng Chen, Fengjuan Su, Haifan Kong, Yating Wang, Chang Yi, Yifan Zheng, Yingying Fang, Xinchong Shi, Yuhao Lin, Jiayi Zhou, Xiangsong Zhang, Zhong Pei

Brain Research · 2026-07 · 1883 · 150283

DOI: 10.1016/j.brainres.2026.150283 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Research, 2026-07. Verfasst von Weineng Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital, Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases…. Hauptthemen laut MEDLINE: Astrocytes, Amyloid beta-Peptides, Alzheimer Disease, Apolipoprotein E4. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Guangdong Provincial Translational Medicine Innovation Platform for Diagnosis and Treatment of Major Neurological Disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND The apolipoprotein E ε4 (APOE ε4), a well-established genetic risk factor for Alzheimer's disease (AD), is deeply involved in amyloid-β (Aβ) and tau pathology. Blood-based biomarkers (BBMs), including Aβ42/40, phosphorylated tau (p-tau181), glial fibrillary acidic protein (GFAP) and neurofilament light (NfL), offer accessible proxies of AD pathology. Reactive astrocytes, indicated by elevated GFAP, are increasingly recognized as key players in AD progression. However, how astrocyte reactivity interacts with APOE genotype to shape BBMs and Aβ deposition remains unclear. METHODS We included 283 participants across the cognitive spectrum including cognitively unimpaired (CU), mild cognitive impairment (MCI), and all-cause dementia (ACD) from Guangzhou health aging and dementia cohort. Primary outcome measures were plasma biomarkers (Aβ42/40 ratio, p-tau181, GFAP, and NfL) and amyloid PET standardized uptake value ratio (SUVR). Participants were stratified by APOE ε4 carrier status and astrocyte activation. Group comparisons, correlation analyses, and sensitivity analyses were performed. RESULTS Stage-dependent APOE effects were observed: while modulating Aβ42/40 ratios in both CU and MCI, APOE influenced p-Tau181 only in MCI, exclusively under Ast-. SUVR was significantly higher in APOE ε4 + group at MCI stage, particularly in Ast- cases. Intriguingly, p-Tau/Aβ42 showed strong SUVR correlations across all subgroups except APOE ε4- Ast- group. DISCUSSION Our findings indicate that astrocyte reactivity is associated with differences in how APOE ε4 relates to both peripheral BBMs and central Aβ deposition, supporting an interplay between genetic risk and neuroinflammatory states in AD pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytesAmyloid beta-PeptidesAlzheimer DiseaseApolipoprotein E4Apolipoproteins EHumansBiomarkersFemaleMaleGlial Fibrillary Acidic ProteinAgedGenotypeCognitive Dysfunctiontau ProteinsAged, 80 and overPeptide FragmentsNeurofilament Proteins

Stichwörter der Autor:innen

APOEAlzheimer’sdiseaseAstrocyte activityAβ burdenBlood biomarkers

Substanzen

Amyloid beta-PeptidesBiomarkersApolipoprotein E4Glial Fibrillary Acidic ProteinApolipoproteins Etau ProteinsPeptide FragmentsNeurofilament Proteins

Autor:innen und Institutionen

  • Department of Neurology, The First Affiliated Hospital, Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department and Key Discipline of Neurology, Su…
  • Department of Nuclear Medicine, The First Affiliated Hospital, Sun Yat-sen University, Zhongshan Second Road, Guangzhou, Guangdong 510080, China.
  • Department of Nuclear Medicine, The First Affiliated Hospital, Sun Yat-sen University, Zhongshan Second Road, Guangzhou, Guangdong 510080, China. Electronic address: zhxiangs@mail.sysu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Guangdong Provincial Translational Medicine Innovation Platform for Diagnosis and Treatment of Major Neurological Disease

Zitieren

APA

Chen, W., Su, F., Kong, H., Wang, Y., Yi, C., Zheng, Y., Fang, Y., Shi, X., Lin, Y., Zhou, J., Zhang, X., & Pei, Z. (2026). APOE genotype and astrocyte activity collectively influence AD biomarkers and Aβ burden. Brain Research, 1883, 150283. https://doi.org/10.1016/j.brainres.2026.150283

Vancouver

Chen W, Su F, Kong H, Wang Y, Yi C, Zheng Y, et al. APOE genotype and astrocyte activity collectively influence AD biomarkers and Aβ burden. Brain Research. 2026;1883:150283. doi:10.1016/j.brainres.2026.150283

BibTeX
@article{Chen2026,
  author = {Chen, Weineng and Su, Fengjuan and Kong, Haifan and Wang, Yating and Yi, Chang and Zheng, Yifan and Fang, Yingying and Shi, Xinchong and Lin, Yuhao and Zhou, Jiayi and Zhang, Xiangsong and Pei, Zhong},
  title = {APOE genotype and astrocyte activity collectively influence AD biomarkers and Aβ burden},
  journal = {Brain Research},
  year = {2026},
  volume = {1883},
  pages = {150283},
  doi = {10.1016/j.brainres.2026.150283}
}
Kostenlos starten →